| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |